Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition

- Islam, Saiful, Rahaman, Muhammed H., Yu, Mingfeng, Noll, Benjamin, Martin, Jennifer H., Wang, Shudong, Head, Richard

Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells

- Islam, Saiful, Teo, Theodosia, Kumarasiri, Malika, Slater, Martin, Martin, Jennifer H., Wang, Shudong, Head, Richard

The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment

- Lumbers, Eugenie R., Head, Richard, Smith, Gary R., Delforce, Sarah J., Jarrott, Bevyn, Martin, Jennifer H., Pringle, Kirsty G.

“LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy

- Jarrott, Bevyn, Head, Richard, Pringle, Kirsty G., Lumbers, Eugenie R., Martin, Jennifer H.

A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19

- Martin, Jennifer H., Head, Richard

Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target

- Islam, Saiful, Wang, Shudong, Bowden, Nikola, Martin, Jennifer, Head, Richard

Repurposing some older drugs that cross the blood-brainier and have potential anticancer activity to provide new treatment options for glioblastoma

- Rundle-Thiele, Dayle, Head, Richard, Cosgrove, Leah, Martin, Jennifer H.

The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells

- Hosein, Abdel Nasser, Lim, Yi Chieh, Day, Bryan, Stringer, Brett, Rose, Stephen, Head, Richard, Cosgrove, Leah, Sminia, Peter, Fay, Michael, Martin, Jennifer H.

Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?

- Fay, Michael, Head, Richard, Martin, Jennifer